Interactive effects of cocaine on HIV infection: Implication in HIV-associated neurocognitive disorder and neuroAIDS

Frontiers in Microbiology

Volumn 6, Issue SEP, 2015, Pages

  Dahal, Santosh ^a   Chitti, Sai V P ^a   Nair, Madhavan P N ^b   Saxena, Shailendra K ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

AIDS; Blood brain barrier; CNS; Cocaine; HAND; HIV; NeuroAIDS

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; JUNCTIONAL ADHESION MOLECULE B; MICRORNA 125B; MITOGEN ACTIVATED PROTEIN KINASE; OCCLUDIN; PLATELET DERIVED GROWTH FACTOR BB; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; APOPTOSIS; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; DRUG ABUSE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VIRUS ENTRY;

EID: 84946718676     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00931     Document Type: Review

References (39)

1. Addai, A. B., Pandhare, J., Mantri, C. K., and Dash, C. (2014). Cocaine enhances HIV-1 integration in CD4+ T cells by modulating the epigenetic DNA signatures of host genome. FASEB. J. 28.776.3.
2. Anthony, J. C., Vlahov, D., Nelson, K. E., Cohn, S., Astemborski, J., and Solomon, L. (1991). New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am. J. Epidemiol. 134, 1175-1189.
3. Atluri, V. S., Pilakka-Kanthikeel, S., Samikkannu, T., Sagar, V., Kurapati, K. R., and Saxena, S. K. (2014). Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. Mol. Brain 7:37. doi: 10.1186/1756-6606-7-37
4. Carvour, M. L., Harms, J. P., Lynch, C. F., Mayer, R. R., Meier, J. L., Liu, D., et al. (2015). Differential survival for men and women with HIV/AIDS-related neurologic diagnoses. PLoS ONE 10:e0123119. doi: 10.1371/journal.pone.0123119
5. Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A., and Moss, A. R. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261, 561-565.
6. Collman, R., Godfrey, B., Cutilli, J., Rhodes, A., Hassan, N. F., Sweet, R., et al. (1990). Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J. Virol. 64, 4468-4476.
7. Cook, J. A. (2011). Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission. Life Sci. 88, 931-939. doi: 10.1016/j.lfs.2011.01.003
8. Diwan, B., Saxena, R., and Tiwari, A. (2013). HIV-2 and its role in conglutinated approach towards acquired immunodeficiency syndrome (AIDS) vaccine development. Springerplus 2, 7. doi: 10.1186/2193-1801-2-7
9. Gandhi, N., Saiyed, Z. M., Napuri, J., Samikkannu, T., Reddy, P. V., Agudelo, M., et al. (2010). Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J. Neurovirol. 16, 294-305. doi: 10.3109/13550284.2010.499891
10. Gaskill, P. J., Yano, H. H., Kalpana, G. V., Javitch, J. A., and Berman, J. W. (2014). Dopamine receptor activation increases HIV entry into primary human macrophages. PLoS ONE 9:e108232. doi: 10.1371/journal.pone.0108232
11. Giros, B., El Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T., et al. (1992). Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383-390.
12. Jacobs, M. M., Murray, J., Byrd, D. A., Hurd, Y. L., and Morgello, S. (2013). HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations. J. Neurovirol. 19, 495-504. doi: 10.1007/s13365-013-0204-8
13. Ison, R., Medoro, L., Keen, N., and Kuipers, E. (2014). The use of rescripting imagery for people with psychosis who hear voices. Behav. Cogn. Psychother 42, 129-142.
14. Kousik, S. M., Napier, T. C., and Carvey, P. M. (2012). The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front. Pharmacol. 3:121. doi: 10.3389/fphar.2012.00121
15. Kumar, M. (2011). Cocaine and the blood-brain-barrier. Blood 24, 117. doi: 10.1182/blood-2010-12-324939
16. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., and Hendrickson, W. A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659.
17. Mantri, C. K., Pandhare, Dash, J., Mantri, J. V., and Dash, C. C. (2012). Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b. PLoS ONE 7:e51387. doi: 10.1371/journal.pone.0051387
18. McIntosh, S., Sexton, T., Pattison, L. P., Childers, S. R., and Hemby, S. E. (2015). Increased sensitivity to cocaine self-administration in HIV-1 transgenic rats is associated with changes in striatal dopamine transporter binding. J. Neuroimmune. Pharmacol. 10, 493-505. doi: 10.1007/s11481-015-9594-0
19. Mishra, M., Taneja, M., Malik, S., Khalique, H., and Seth, P. (1989). Human immunodeficiency virus type 1 Tat modulates proliferation and differentiation of human neural precursor cells: implication in neuroAIDS. J. Neurovirol. 16, 355-367. doi: 10.3109/13550284.2010.513028
20. Nair, M. P., and Samikkannu, T. (2012). Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine. Curr. HIV. Res. 10, 429-434. doi: 10.2174/157016212802138742
21. Pandhare, J., Addai, A. B., Mantri, C. K., Hager, C., Smith, R. M., Barnett, L., et al. (2014). Cocaine enhances HIV-1-induced CD4+ T-cell apoptosis: implications in disease progression in cocaine-abusing HIV-1 patients. Am. J. Pathol. 184, 927-936. doi: 10.1016/j.ajpath.2013.12.004
22. Peters, P. J., Bhattacharya, J., Hibbitts, S., Dittmar, M. T., Simmons, G., Bell, J., et al. (2004). Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J. Virol. 79, 6915-6926. doi: 10.1128/JVI.78.13.6915-6926.2004
23. Rafie, C., Campa, A., Smith, S., Huffman, F., Newman, F., and Baum, M. K. (2011). Cocaine reduces thymic endocrine function: another mechanism for accelerated HIV disease progression. AIDS. Res. Hum. Retroviruses. 27, 815-822. doi: 10.1089/AID.2010.0086
24. Reddy, P. V., Pilakka-Kanthikeel, S., Saxena, S. K., Saiyed, Z., and Nair, M. P. (2012). Interactive effects of morphine on HIV infection: role in HIV-associated neurocognitive disorder. AIDS. Res. Treat. 2012, 10. doi: 10.1155/2012/953678
25. Reynolds, J. L., Mahajan, S. D., Aalinkeel, R., Nair, B., Sykes, D. E., Agosto-Mujica, A., et al. (2009). Modulation of the proteome of peripheral blood mononuclear cells from HIV-1-infected patients by drugs of abuse. J. Clin. Immunol. 29, 646-656. doi: 10.1007/s10875-009-9309-5
26. Rinaldo, C. R. (2013). HIV-1 trans infection of CD4+ T cells by professional antigen presenting cells. Scientifica (Cairo). 2013, 30. doi: 10.1155/2013/164203
27. Rudnick, G. (2011). Cytoplasmic permeation pathway of neurotransmitter transporters. Biochemistry 50, 7462-7475. doi: 10.1021/bi200926b
28. Saiyed, Z. M., Gandhi, N., Agudelo, M., Napuri, J., Samikkannu, T., and Reddy, P. V. (2011). HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND). Neurochem. Int. 58, 656-664. doi: 10.1016/j.neuint.2011.02.004
29. Samikkannu, T., Agudelo, M., Gandhi, N., Reddy, P. V., Saiyed, Z. M., Nwankwo, D., et al. (2011). Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: implications for neuroAIDS. J. Neurovirol. 17, 230-238. doi: 10.1007/s13365-011-0026-5
30. Saxena, S. K., Gupta, A., Bhagyashree, K., Saxena, R., Arora, N., Banerjee, A. K., et al. (2002). Targeting strategies for human immunodeficiency virus: a combinatorial approach. Mini. Rev. Med. Chem. 12, 236-254. doi: 10.2174/1389557511209030236
31. Sundaravaradan, V., Saxena, S. K., Ramakrishnan, R., Yedavalli, V. R., Harris, D. T., and Ahmad, N. (2006). Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 103, 11701-11706. doi: 10.1073/pnas.0602185103
32. Tiwari, S., Nair, M. P., and Saxena, S. K. (2013). Latest trends in drugs of abuse-HIV infection and neuroAIDS. Future. Virol. 8, 121-127. doi: 10.2217/fvl.12.134
33. United Nations Office on Drugs and Crime (UNODC). (2012). World Drug Report 2012. United Nations publication, Sales No. E.12.XI.1. New York: UNODC.
34. Wachtman, L. M., Skolasky, R. L., Tarwater, P. M., Esposito, D., Schifitto, G., Marder, K., et al. (2007). Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus-associated dementia. Arch. Neurol. 64, 1264-1272. doi: 10.1001/archneur.64.9.1264
35. Yang, Y., Yao, H., Lu, Y., Wang, C., and Buch, S. (2010). Cocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120. PLoS ONE 5:e13427. doi: 10.1371/journal.pone.0013427
36. Yao, H., Allen, J. E., Zhu, X., Callen, S., and Buch, S. (2009). Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways. J. Neurovirol. 15, 164-175. doi: 10.1080/13550280902755375
37. Yao, H., Duan, M., Yang, L., and Buch, S. (2012). Platelet-derived growth factor-BB restores human immunodeficiency virus Tat-cocaine-mediated impairment of neurogenesis: role of TRPC1 channels. J. Neurosci. 32, 9835-9847. doi: 10.1523/JNEUROSCI.0638-12.2012
38. Yuan, Y., Huang, X., Midde, N. M., Quizon, P. M., Sun, W. L., Zhu, J., et al. (2015). Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter. ACS. Chem. Neurosci. 6, 658-665. doi: 10.1021/acschemneuro.5b00001
39. Zenón, F., Segarra, A. C., Gonzalez, M., and Meléndez, L. M. (2014). Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J. Neuroimmune Pharmacol. 9, 703-715. doi: 10.1007/s11481-014-9563-z